(Correcting the description of the company in the third paragraph)

China Resources Medical (HKG:1515) recorded a rise in attributable profit for the year 2024 to 565.9 million yuan from 257.7 million yuan a year prior, a Tuesday filing with the Hong Kong bourse said.

Earnings per share were 0.45 yuan in the year, up from 0.20 yuan in the last fiscal year.

The hospital business firm's revenue fell to 9.85 billion yuan in the period from 10.1 billion yuan a year prior.

The company has proposed a final dividend of 0.082 yuan per share for the year, payable on or before July 21 to shareholders of record on June 12.